S0077 HCPCS Level II code: Injection, clindamycin phosphate, 300 mg
CMS terminated S0077: its last date of service was Jun 30, 2023. It stays here for looking up older claims; newer services need a current code.
Official description
S0077Injection, clindamycin phosphate, 300 mg
Short description: Injection, clindamycin phosp
HCPCS · United States
Notes for S0077
As CMS prints them, with any note S0077 takes from the headings above it.
Note
- CMS processing note 0088: "S" CODES ARE UNIQUE TEMPORARY CODES ESTABLISHED BY BCBSA AND HIAA FOR PRIVATE PAYOR USE. THEY ARE NOT VALID NOR PAYABLE BY MEDICARE.
Medicare details
The indicators CMS publishes with S0077 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Not payable by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Undefined codes
- Added
- Jan 1, 2000
- Terminated after
- Jun 30, 2023
Where S0077 sits
- 1S codesTemporary national codes (non-Medicare)
- 2Terminated S0077Injection, clindamycin phosphate, 300 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code S0077 still valid?
No. CMS terminated S0077; its last date of service was Jun 30, 2023. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover S0077?
CMS lists S0077’s Medicare coverage as “Not payable by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside S0077
All S codesS0032Injection, nafcillin sodium, 2 gramsS0034Injection, ofloxacin, 400 mgS0039Injection, sulfamethoxazole and trimethoprim, 10 mlS0040Injection, ticarcillin disodium and clavulanate potassium, 3.1 gramsS0073Injection, aztreonam, 500 mgS0074Injection, cefotetan disodium, 500 mgS0078Injection, fosphenytoin sodium, 750 mgS0080Injection, pentamidine isethionate, 300 mgS0081Injection, piperacillin sodium, 500 mgS0088Imatinib, 100 mgS0090Sildenafil citrate, 25 mgS0091Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166)